Main > ONCOLOGY (**) > Lung>NSCLC>MET>HER2 Mutant> > JP. D. Treat.: HER2 ADC Inj.

---

JP. D. Treat.: HER2 ADC Inj.'s subsections
(*) USA Approval Date> 2022. 08.11
>Companion Diagnostic Test
>Prior Systemic Therapy
Company
Company Partner
Generic Name
RTM
RTM Web-Site
USA Patent Numbers

JP. D. Treat.: HER2 ADC Inj.'s products
This section has no products